Prediction of bleeding risk in patients taking vitamin K antagonists using thrombin generation testing

Until recently, vitamin K antagonists (VKAs) were the mainstay of oral anticoagulant treatment with bleeding as the most prevalent adverse effect. One to four percent of patients experience major bleeding episodes, while clinically relevant bleeding occurs in up to 20%. At this moment no laboratory...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS One
Main Authors: Bloemen, Saartje, Zwaveling, Suzanne, ten Cate, Hugo, ten Cate-Hoek, Arina, de Laat, Bas
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2017
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5417600/
https://ncbi.nlm.nih.gov/pubmed/28472104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0176967
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki